Use of Rituximab for persistent EBV DNAemia, and Its effect on donor‐specific antibody development in pediatric renal transplant recipients: A case series-Reference-Cited by-同舟云学术

Use of Rituximab for persistent EBV DNAemia, and Its effect on donor‐specific antibody development in pediatric renal transplant recipients: A case series

Published:2021-08-21 Issue:8 Volume:25 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatric Transplantation

Author:

Puliyanda Dechu P¹^ORCID,Jordan Stanley C²,Kim Irene K.²^ORCID,Patel Mitasha¹,Murthy Anand¹,Huang Edmund²^ORCID,Zhang Xiaohai³,Reinsmoen Nancy³,Kamil Elaine S¹,Toyoda Mieko⁴

Affiliation:

1. Pediatric Nephrology and Transplant Immunology Cedars‐Sinai Medical Center Los Angeles CA USA

2. Comprehensive Transplant Center Cedars‐Sinai Medical Center Los Angeles CA USA

3. HLA and Immunogenetics Laboratory Cedars‐Sinai Medical Center Los Angeles CA USA

4. Transplant Immunology Laboratory Cedars‐Sinai Medical Center Los Angeles CA USA

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.14113

Reference41 articles.

1. RISK FACTORS FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN PEDIATRIC KIDNEY TRANSPLANTATION: A REPORT OF THE NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT COOPERATIVE STUDY (NAPRTCS)1

2. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients

3. Pretransplantation seronegative Epstein‐Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations;Walker RC;J Heart Lung Transplant,1995

4. Pretransplantation Assessment of the Risk of Lymphoproliferative Disorder

5. B-cell regulation and its application to transplantation

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of pre‐emptive rituximab on EBV DNA levels and prevention of post‐transplant lymphoproliferative disorder in pediatric kidney transplant recipients: A case series from the pediatric nephrology research consortium;Pediatric Transplantation;2024-04-02

2. Longitudinal analysis of the impact of rituximab on circulating EBV miRNAs in three paediatric kidney transplant recipients;Journal of Clinical Virology Plus;2024-02

3. Risk Factors Associated with PTLD Related Mortality in Adult Multivisceral Transplant Recipients - A Single Centre Cohort Study;Chirurgia;2024

4. Screening and Management of PTLD;Transplantation;2023-10-21

5. Pre-Existing Intrarenal Parvovirus B19 Infection May Relate to Antibody-Mediated Rejection in Pediatric Kidney Transplant Patients;International Journal of Molecular Sciences;2023-05-23